Physicians are advised to discuss the following issues with patients for whom they prescribe ASIMIA^TM (paroxetine mesylate):

Interference with Cognitive and Motor Performance: Any psychoactive drug may impair judgment, thinking or motor skills. Although in controlled studies paroxetine has not been shown to impair psychomotor performance, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that paroxetine therapy does not affect their ability to engage in such activities.

Completing Course of Therapy: While patients may notice improvement with paroxetine therapy in 1 to 4 weeks, they should be advised to continue therapy as directed.

Concomitant Medication: Patients should be advised to inform their physician if they are taking, or plan to take, any prescription or over-the-counter drugs, since there is a potential for interactions.

Alcohol: Although paroxetine has not been shown to increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking ASIMIA^TM.

Pregnancy: Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy.

Nursing: Patients should be advised to notify their physician if they are breast-feeding an infant (see PRECAUTIONS-Nursing Mothers).

There are no specific laboratory tests recommended.

Bookmark this page: